SNIDER LINDY reported 1 transaction at NEXIEN BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/29/2018ACC: 0001214659-18-004623
0.00
Net shares
Net seller
$15.2K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
40K acquired · 40K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+40K
Price / share
$0.38
Trade value
$15.20K
% of position
9.1%
6/19/2018
440K→480K
Total
Net shares
+40K
Net value
$15.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/19/2018 | X · X | +40K | $0.38 | $15.20K | 9.1% | 440K | 480K |
| Total | +40K | $15.20K | ||||||
Derivative Transactions1
Class B Warrants (right to buy)
Direct
Converts to
Common Stock
40K shares
Shares
−40K
Strike price
0.38
Held after
0.00
Exercisable
—
6/19/2018
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Class B Warrants (right to buy) Direct | Common Stock40K shares | 6/19/2018 | X · X | −40K | 0.38 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)1
Class C Warrants (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
40K
Shares owned
40K
Exercise price
0.50
Expiration
—
Exercise window
—
Total
Underlying
40K
Owned
40K
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Class C Warrants (right to buy) Direct | Common Stock | 0.50 | — | — | 40K | 40K |
| Total | 40K | 40K | ||||